The company offers integrated services across the drug discovery, development, and manufacturing lifecycle for both NCEs and NBEs, including specialised fermentation-based APIs ...

Anthem Biosciences IPO opened for subscription on July 14, 2025, with a total issue size of Rs 3,395 crore via offer for sale. Priced in the Rs 540–570 band, ...

Ahead of the initial share sale opening for public subscription, the unlisted shares of Anthem Biosciences were trading at ...

Anthem Biosciences launched its IPO on July 14, featuring an offer for sale of Rs 3,395 crore. The Bengaluru-based CRDMO, ...

Anthem Biosciences IPO opens with ₹3,395 crore offer, price band set at ₹540-570 per share, targeting global pharmaceutical market.

Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on ...

JM Financial Limited is acting as the book-running lead manager to the issue, and KFin Technologies Limited is the registrar.

The mainboard issue of the research-driven drug manufacturer opens for subscription on July 14. Here's everything you must ...

The IPO market remains active with 90 companies having filed their Draft Red Herring Prospectus (DRHP) with SEBI in the ...

Anthem Biosciences IPO: The Bengaluru-based company, Anthem Biosciences, has secured Rs 1,016 crore from anchor investors ...

Anthem Biosciences, Spunweb Nonwoven, and Monika Alcobev—are set to launch IPOs aiming to raise over Rs 3,600 crore amid ...